Home > Insider Trading > Filing (0001209191-17-056612)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1649904	Rhythm Pharmaceuticals Inc.	RYTM	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1134655	Ansbert Gadicke	C/O Mpm Asset Management 450 Kendall Street Cambridge MA 02142	No	No	Yes	No
1134657	Luke Evnin	C/O Mpm Asset Management 450 Kendall Street Cambridge MA 02142	No	No	Yes	No
1482714	Mpm Bioventures V Gp Llc	C/O Mpm Asset Management 450 Kendall Street Cambridge MA 02142	No	No	Yes	No
1482715	Mpm Bioventures V Llc	C/O Mpm Asset Management 450 Kendall Street Cambridge MA 02142	No	No	Yes	No
1482716	Mpm Bioventures V, L.p.	C/O Mpm Asset Management 450 Kendall Street Cambridge MA 02142	No	No	Yes	No
1541412	Mpm Asset Management Investors Bv5 Llc	C/O Mpm Asset Managment 450 Kendall Street Cambridge MA 02142	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-10-10	2,567,014	$0.00	2,596,392	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2017-10-10	100,000	$17.00	2,696,392	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2017-10-10	7,651,831	$0.00	834,441	$0.00
Common Stock	Series A-1 Junior Preferred Stock	Disposition	2017-10-10	15,887,703	$0.00	1,732,573	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

Each share of preferred stock converted into approximately 0.10905125 shares of common stock upon the closing of the issuer's initial public offering. The shares had no expiration date.
The shares are held as follows: 2,499,299 by MPM BioVentures V, L.P. ("BV V") and 97,093 by MPM Asset Management Investors BV5 LLC ("AM BV5"). MPM BioVentures V GP LLC and MPM BioVentures V LLC ("BV LLC") are the direct and indirect general partners of BV V and BV LLC is the manager of AM BV5. Ansbert Gadicke, Luke Evnin and Todd Foley are the members of BV LLC. Mr. Foley is a director of the Issuer and has separately filed a Form 4. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
Shares were purchased as follows: 96,260 by BV V and 3,740 by AM BV5.
Shares are held as follows: 2,595,559 by BV V and 100,833 by AM BV5. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
The shares of Series A Preferred Stock were held as follows: 7,365,688 by BV V and 286,143 by AM BV5.
The shares of Series A-1 Junior Preferred Stock were held as follows: 15,293,569 by BV V and 594,134 by AM BV5.